INTRODUCTION
In recent years, tendencies of scientific research focused on the discovery of new biomaterials that would overcome the shortcomings of the existing ones through changes in composition and improved characteristics. In contact with tissue, biomaterials must not exhibit potential cytotoxic, genotoxic, mutagenic, or allergic reactions [1] .
Biocompatibility tests are carried out in vitro and in vivo conditions and include testing of materials in laboratory conditions on cell tissues or organ cultures, animal experiments, and clinical tests on humans. The efficiency of animal tests is more important than in vitro research. These tests are carried out by using subcutaneous implantation, allergy tests, and tests of acute and chronic systemic toxicity of dental materials [2] .
Calcium aluminate cements (CAC) were developed at the beginning of the 20th century as chemically durable materials from Portland cement. Their hydraulic calcium phase contains 30-50% of aluminum, while in Portland cement, aluminum is less than 5% [3, 4, 5] .
More thorough studies of the potential biomedical application of calcium aluminate cements have been carried out a decade ago.
Attempts of calcium aluminates use in dentistry for direct restorative fillings on lateral teeth (DoxaDent; Doxa AB, Uppsala, Sweden) (Ceramir C&B, Doxa AB), during a three-year clinical monitoring did not indicate clinical success, due to inferior mechanical properties and handling difficulties [6, 7] .
Calcium aluminate in addition to X-ray contrast agent, mixed with water or 0.9% saline solution, resulted in an endodontic cement of similar indications as commercially available tricalcium silicate cements (EndoBinder, Binderweare, Sao Carlos, SP, Brazil). EndoBinder was developed with the intention of preserving the positive properties and clinical application of mineral trioxide aggregate (MTA), but without its negative properties. According to the results of several recent studies, EndoBinder showed appropriate biological and physico-chemical characteristics, good antimicrobial activity against Enterococus fecalis, Staphylococcus aureus, and Candide albicans, and after the implantation into subcutaneous tissue of rats caused a minor inflammatory reaction compared to MTA or an inflammatory reaction similar to MTA [8] [9] [10] [11] . During the repair of bone defects, Endo-Binder showed similar behavior as MTA, and stimulated complete bone recovery after three months [12] .
Quick-set (Primus Consulting, Bradenton, FL, USA), calcium aluminate cement, confirmed the dentinogenic potential as White Mineral Trioxide Aggregate (Dentsply Tulsa Dental Specialties, Tulsa, OK, USA) in in vitro conditions on the MDPC-23 odontoblast cell line and in vivo conditions in pulpotomy [13, 14] .
Attempts of combining calcium aluminate cements (CAC) with collagen, zirconium, zinc oxide, tricalcium phosphate, and hydroxyapatite have shown great potential for application in odontology and orthopedics. Compared with commercial products for implementation in dentistry (MTA, glass ionomer cement Vidrion; SSWhite Duflex, São Cristovão, RJ, Brasil) and orthopedics (polymethyl methacrylate), CAC mixtures showed greater alkaline phosphatase activity, higher cellular viability of osteoblast cells, and formation apatite on the surfaces of all CAC samples of homogeneous layer [15] .
The combination of tricalcium aluminates (Ca 3 Al 2 O 6 ) with tricalcium silicates (Ca 3 SiO 5 ) resulted in better physico-chemical properties (accelerated the hydration process, reduced the setting time and improved the compressive strength), higher bioactivity and biocompatibility (stimulating effect on L929 cell growth) compared to pure tricalcium silicates (Ca 3 SiO 5 ) [16] .
Despite the fact that in the last decade the emphasis has been placed on research of calcium aluminate cements, wider use of these materials in dental practice requires additional testing of a recent date.
Research on new calcium aluminates with similar physical and biological properties as well as MTA, but without its negative characteristics are still current.
Simultaneously, there is a growing influence of nanotechnology and nanomaterials in medicine.
The objective of this study was to investigate the biocompatibility of the newly synthesized nanostructured material based on calcium aluminate after implantation into the subcutaneous tissue of rats.
METHODS
The research was conducted after the approval of the Ethics Committee of the University Clinical Center in Banja Luka, No. 01-9-192.2/15, Bosnia and Herzegovina, and an experiment was realized at the Vivarium of the Faculty of Natural Sciences and Mathematics, University of Banja Luka, and in the Laboratory of the Institute of Pathology, Banja Luka Clinical Center.
Tested materials
The calcium aluminate-based nanomaterial system (AL-BO-CA) was compared to the hydroxyapatite and calcium silicate-based material (ALBO-CSHA). White Mineral Trioxide Aggregate (MTA Angelus® Tulsa OK, USA) was used as a positive control. The calcium aluminate system (CaO • Al 2 O 3 + CaCO 3 + Bi 2 O 3 ) is a mixture called ALBO-MCCA, obtained by mixing CaCO 3 and Bi 2 O 3 , and BaSO 4 with a calcium aluminate phase in the ratio of 2:2:1. In order to obtain calcium aluminate endodontic mixtures, it was first necessary to synthesize particular components of the mixture: calcium aluminate (CaO • Al 2 O 3 , CA) and calcite (CaCO 3 ). The mixture was finally mixed with distilled water in the 2:1 ratio of powder to water, according to the recommended protocol.
Another test material was calcium silicate with the addition of hydroxyapatite. Both of the materials were synthesized according to the method of Professor Jokanović and his associate using new technology, a combination of hydrothermal sol-gel method and the method of selfcombusting waves [17] .
Design of the study
The animal model comprised rats of the Wistar strain (18 rats, aged 10-11 weeks, with the average weight of 190-280 g). During the experiment, the rats had free access to food and water, 12-hour shifts of light and dark, air temperature ranged 20-23°C, and humidity was 60% ± 10%. The rats were divided into two experimental groups (n = 9). Six rats (three from each group) were sacrificed after seven, 15 and 30 days. Subcutaneous implantation of polyethylene tubes (length 10 mm, inner diameter 1 mm) was conducted, up to half filled with tested materials (ALBO-CA in group I, ALBO-CSHA in group II) and half empty. The empty half of the tube was the negative control. Two tubes were placed on the back of each rat, on the right side of the tube with the tested material, and on the left side of the spinal column of the tube with the MTA (positive control). The tubes were oriented so that the material was always turned toward the head, and the empty part of the tube to the tail.
Before the surgical procedure, the rats were put under general anesthesia (ketamine, 90 mg / kg of body weight, Ketamine Hydrochloride Injection USP, Rotexmedica GmbH Arzneimittelwerk, Trittau, Germany, in combination with xylazine, 5 mg / kg of body weight, 2% Xylazine, Cp Pharma, Bergdorf, Germany).
Preparation of the operational field was carried out, and then a blunt dissection, right and left of the spinal column, two pockets about 15 mm deep were formed. Sterile polyethylene tubes, previously filled with freshly mixed test materials, were placed in the pockets in this way. After that, the wound was sewed. The individual knotted seam was applied.
After the operation, the animals were placed in one cage in the controlled environment, with controlled diet and daily professional care.
Animal health control was carried out three times a day. Six animals were sacrificed in each observation period (seven, 15, 30 days). For this purpose, intravenous injection of pentobarbital (pentobarbital sodium salt, 100 mg/ ml, Sigma-Aldrich Chemie GmbH, Steinheim, Germany) was used.
Prepared subcutaneous tissue, together with tubes, was immersed in 10% formalin and delivered to laboratories for histological analysis.
For histological analysis, four samples were taken from each animal. After that, tissue clip fixation together with polyethylene tubes was performed in 10% buffered formalin, followed by paraffin molding and paraffinic dyeing by hematoxylin and eosin (4 μm thickness slices). The analysis of the preparation was done on a light microscope (Olympus BX-51, Olympus Corporation, Tokio, Japan) by an experienced pathologist, who did not participate in the sampling of the material.
Histological analysis of the prepared samples was performed qualitatively and semi-quantitatively, and the inflammatory reaction, vascular congestion, fibrous capsule, and the preservation of the integrity of the connective tissue were considered.
Statistical analysis
Dunn's post-hoc test was applied for the significance of differences between pairs with a significance level of = 0.05 for statistical analysis of the obtained subcutaneous implantation results. Statistical analysis was done in the Minitab 16 software package (Minitab INC, State College, PA, USA). Table 1 and Figures 1-7 .
RESULTS

Results of the histological analysis are shown in
After a seven-day histopathological analysis, a moderate inflammatory reaction was recorded (grade 3) with calcium aluminate ALBO-CA and calcium silicate hydroxyapatite ALBO-CSHA, while inflammatory reaction with MTA was moderate (grade 3) in three cases, and an intensive inflammatory reaction (grade 4) was noted in three cases, with a statistically significant difference (p = 0.2781). Moderate inflammation was traced by moderate vascular congestion with ALBO-CA (grade 3) and ALBO-CSHA material. After MTA implantation, equally moderate distribution (grade 3) and pronounced vascular congestion were observed (grade 4). In all tested materials, a moderate distortion of the connective tissue structure was registered, while the fibrous capsule after the implantation of ALBO-CA material was minimal (grade 1), i.e. minimal (grade 1) or absent (grade 0) after the implantation of ALBO-CSHA and MTA (Figures 1 and  2) . The difference in vascular congestion and the thickness of the fibrous capsule after implantation of ALBO-CA material relative to MTA was statistically significant (p = 0.5567).
In the control preparations, seven days after subcutaneous implantation, the presence of moderate intensity inflammatory reaction and one case of pronounced inflammatory reaction was noted in the control of the ALBO-CA material and the MTA control. Blood vessels showed signs of moderate vascular congestion, which was more expressed in the control group of MTA. In all control preparations, there was a moderate disturbance of connective tissue structure, except in one case of the MTA control group with a slightly disrupted connective tissue structure (grade 2). The fibrous capsule was absent in all control preparations of ALBO-CA, and in most of the preparations of the MTA control group, except in one case. Material control of ALBO-CSHA recorded a gentle thin capsule in two cases (grade 1), and complete absence of the capsule in one sample (grade 0).
A pathohistological analysis after 15 days at the site of implantation of all examined materials showed a slight inflammatory reaction thin or moderately thick fibrous capsule (Figures 3 and 4) , and a mild disturbance of the connective tissue structure (grade 2). Vascular congestion is characterized as mild (grade 2) with the ALBO-CA material, or as moderate or mild to ALBO-CSHA and MTA, with a statistically significant difference (p = 0.2974).
In control preparations after 15 days, the weakest inflammatory response was recorded in the ALBO-CSHA control (grade 2), while control preparations for ALBO-CA were rated with mark 3 (moderate inflammatory response), and for MTA the score was 2.3 (mild to moderate inflammatory reaction). In all control preparations, a slight disturbance of the structure of the loose connective tissue (grade 2) was observed, followed by the formation of a thin fibrous capsule (grade 2). Vascular congestion was equally expressed in control group of ALBO-CSHA and MTA (grade 2.3), while in the ALBO-CA control, the score was rated 2.6.
At the end of the evaluation period of 30 days, an identical inflammatory response of loose connective tissue at the site of implantation ALBO-CA, ALBO-CSHA, and MTA (score of 0.7) was recorded. The formation of thick or moderately thick fibrous capsules ( Figures 5 and 6 ) was established, which was the thickest with ALBO-CA (grade 3.7). There were no statistically significant differences between the analyzed parameters.
In control preparations after 30 days, a weaker inflammatory response, lower vascular congestion, and better integrity of the binders were observed in control samples of ALBO-CSHA and MTA (grade 0.7), compared with ALBO-CA control (grade 1). A moderately thick or thick fibrous capsule was formed (Figure 7) , thicker in the control of the MTA material (grade 3.2), while the ALBO-CA and ALBO-CSHA controls were rated 3.
DISCUSSION
Animal testing is a common method of checking new materials before their clinical examination.
There are almost no species and subspecies in the animal world that have not been used for the purposes of scientific research. However, when it comes to dental research, preference is given to rats. Although there are now hundreds of pureblooded and about fifty crossed rat strains, the strains most commonly used in dental experiments are from Wistar and Sprague-Dawley strains. The advantage in dental research for these experimental animals is primarily the similarity between their and human molars. In addition, rats cannot vomit and are therefore frequently used as a starting model for numerous toxicity and carcinogenicity tests of dental materials. Of course, the advantage is their reasonable price and the possibility of simple securing. Like mice, rats have good reproductive skills and are well-grown in laboratory conditions [18] .
Subcutaneous implants in rats are often used to evaluate the biological compatibility of various dental materials. The widespread use of this method comes from the fact that the implantation of the material into the subcutaneous tissue of the animal is accessible and simple, but also reliable in order to determine tissue irritation and the interaction between the tissue and the material itself [4, 11, 17] . Local reactions to the implant can be quantitatively and qualitatively evaluated using various methods: histological analysis, scanning electron microscopy, transmission electro-microscopy, histochemical analysis. However, the most common method for studying tissue compatibility of implanted material is histological analysis, and thickness of the fibrous capsule around the implant that is under the skin, which has been used as an indicator of the biocompatibility of the material for decades [19] .
Although a wide range of different types of tubes are in use today -dentine [20] , silicone [21] , Teflon [3] , polyethylene [22] , polypropylene [23] -our choice were polyethylene tubes, considering their inert nature and wide application. They do not cause a tissue reaction and in controlled and effective way expose tested material to the living tissue. They are easy to apply and sterilize [11, 17, 22] .
Tissue around the tested materials showed the highest level of inflammation in the first seven days, with moderate damage to the structure of the connective tissue. The connective tissue around the MTA showed signs of the most severe inflammatory reaction evaluated as moderate and pronounced inflammation. This is in line with the findings of some other researchers (Lotfi et al. [24] , Camilleri and Pitt Ford [25] ) according to which a slightly more expressed initial inflammatory response to tissue implantation by MTA is explained by high pH of this material, longterm follow-up of heat-trapping, as well as the stimulation of inflammatory cytokines.
In accordance with our results are also the results of the study by Opačić-Galić et al. [22] , where seven days after the subcutaneous implantation of the nanostructured CS-HA, CS and the control MTA, in rats of the Wistar strain, the strongest inflammatory response was given by MTA (3.30 ± 0.48), while for CS and CS-HA it was graded with 3.00 ± 0.71.
The results of this research showed the correlation between the strength of the inflammatory response and the thickness of the fibrous capsule. With time lag, a decrease in intensity of inflammation was noticed, with an increase in the thickness of the fibrous capsule in all tested materials. Experimental calcium aluminate cement (ALBO-CA) at the end of the observation period, after 30 days, caused an identical tissue reaction such as calcium silicate hydroxyapatite (ALBO-CSHA) and commercial mineral trioxide aggregate (MTA), with the best organized fibrous capsule around the material, which is probably due to the chemical nature and method of synthesis of this cement. The bioactivity of one material is also related to the method of its synthesis. The calcium aluminate nanostructured biomaterial, which was tested in this study, was produced by nanotechnology, by combining two methods: hydrothermal sol-gel method and the self-combusting wave methods. According to Chen et al. [26] , the materials obtained by sol-gel processes are more bioactive than those obtained by other synthetic methods.
Garcia Lda et al. [4] obtained biocompatibility results that fully correspond to the results of this study in the absence of inflammation and a significant increase in the thickness of fibrous capsule after 30 days of subcutaneous implantation of calcium aluminate cement (EndoBinder), calcium silicate cement (mineral trioxide aggregates) and calcium hydroxide in rats. Despite the fact that EndoBinder releases a lower amount of calcium ions, it caused a tissue reaction similar to that induced by MTA and calcium hydroxide in all observation periods. The authors explain this by the methodology applied in this in vivo study. Garcia Lda et al. [4] concluded that, from the biological point of view, EndoBinder became a promising option in endodontic therapy, but with the recommendation that additional research into the biological and physical-chemical properties of this new cement could be carried out before its application in the endodontic therapy of human populations.
Aminozarbian et al. [27] confirmed that the inflammatory response of the tissue to the implantation of CAAC calcium aluminate cement and the mixture of volostonite and calcium aluminate cement of WOLCA was, after 30 days, in rats comparable to MTA, which is in accordance with our findings, while CAAC Plus did not confirm biocompatibility as it induced a more intense inflammatory response than MTA. The authors explain this by the composition of CAAC Plus cement, with adding 5% Na-HMP dispersant in order to improve its properties, which on the other hand negatively affected biocompatibility [27] .
Aguilar et al. [11] confirmed a better tissue reaction after calcium aluminate cement EndoBinder was compared to GMTA after 42 days of subcutaneous implantation of these materials in rat tissue. This is explained by the process of EndoBinder's synthesis, low Ca content, which results in the release of a smaller amount of calcium ions, making it less irritant and cytotoxic to the tissues, without compromising its antimicrobial properties [11] .
The reaction of the tissue to the empty tubes (negative control) in this experiment is similar to the findings of other researchers [19, 28] . After seventh day, the most pronounced inflammatory response was confirmed, and this initial inflammatory reaction to the empty tubules was explained by the reaction to the surgical implantation procedure [19, 28] .
Results of the biocompatibility of ALBO-CSHA obtained in this study correspond to the findings of Petrović et al. [17] and Saghiri et al. [29] . In their studies, at the end of the observation, there was no significant difference in the tissue inflammatory response to CS-HA and MTA, i.e. BioAggregate, nanostructured tricalcium silicate cement with the addition of calcium phosphate, and MTA after subcutaneous implantation in rats. The authors explain this finding by the fact that calcium-containing good biological properties owe a common ability to released calcium ions, and a similar reaction is expected in a situation where the new calcium silicate system comes into contact with tissue fluids. In the study by Petrović et al. [17] , the application of a special synthesis method further favored the bioactivity of the examined CS-HA.
Contrary to this, Batur et al. [30] have come up with results that are inconsistent with the results of this study, as they confirmed statistically significantly better tissue response and a weaker inflammatory response of DiaRoot BioAggregate compared to MTA. A possible reason for a better BioAggregate result may be the fact that their research was done in vivo conditions on laboratory animals (Sprague-Dawley rats), as opposed to previous in vitro studies, in which no statistically significant difference was found between MTA and BioAggregat [30] .
